Turning Lab Visions into Certified Reality
CLIA, CAP, and State-compliant Quality Systems to support your assay needs.

CLIA, CAP, and State-compliant Quality Systems to support your assay needs.

This is about your vision and your laboratory. Whether you are a seasoned laboratory professional or new to the patient testing field, we will work with you to get your facility certified and operationally ready. It is just that simple.

Regulatory & Accreditation Representation
(CLIA, CAP, State)

Customized Quality Documents (Policies, Procedures, Forms...)

Complete Quality Assurance Program
(From Quality Plan to Launch)

Equipment Qualification

Training & Training Records
(NCE, CAPA, and many more)

I am a quality systems leader with over 15 years of experience building and scaling robust Quality Management Systems (QMS) for clinical, diagnostic, and GLP laboratories. I have designed and implemented comprehensive quality programs encompassing change control, CAPA, equipment validation, risk-based software verification, audit readiness, and regulatory compliance with CLIA, CAP, NYSDoH, GLP, and GCP standards. I have led organizations through successful external inspections (CLIA, CAP, NYS, CDPH, and CROs), licensed laboratories in multiple states, and driven measurable process improvements. Combining deep technical expertise in molecular diagnostics with an MBA in Management and Quality Improvement, I look forward to helping you an inspection-ready quality infrastructure that enable operational excellence and regulatory success!
Message us with questions and to setup a call.
Milford, CT
Today | By Appointment |
Standard Operating Procedures (SOPs) are required under CLIA regulations (42 CFR §493) to ensure that laboratory testing is performed in a consistent, accurate, and reproducible manner. CLIA mandates that laboratories maintain written procedures for all phases of testing—including pre-analytic, analytic, and post-analytic processes—and that personnel follow these procedures to ensure the reliability and integrity of patient results. Similarly, CLSI standards emphasize the development, implementation, and control of SOPs as foundational elements of a quality management system. CLSI guidance outlines that SOPs must be clear, controlled, current, and readily accessible to staff, and must define responsibilities, step-by-step methods, quality control requirements, and documentation practices. Together, CLIA and CLSI require SOPs to reduce variability, support regulatory compliance, promote staff competency, and ensure the generation of accurate and clinically reliable laboratory results.
Standard Operating Procedures (SOPs) are required under CLIA regulations (42 CFR §493) to ensure that laboratory testing is performed in a consistent, accurate, and reproducible manner. CLIA mandates that laboratories maintain written procedures for all phases of testing—including pre-analytic, analytic, and post-analytic processes—and that personnel follow these procedures to ensure the reliability and integrity of patient results. Similarly, CLSI standards emphasize the development, implementation, and control of SOPs as foundational elements of a quality management system. CLSI guidance outlines that SOPs must be clear, controlled, current, and readily accessible to staff, and must define responsibilities, step-by-step methods, quality control requirements, and documentation practices. Together, CLIA and CLSI require SOPs to reduce variability, support regulatory compliance, promote staff competency, and ensure the generation of accurate and clinically reliable laboratory results.
CLIA regulations (42 CFR §493) require that laboratory personnel receive appropriate training and demonstrate competency prior to performing patient testing, with ongoing assessments to ensure continued competency. Laboratories must document initial training, including instruction on test methods, instrumentation, quality control, safety, and applicable procedures, as well as maintain records of competency assessments conducted at defined intervals (e.g., semiannual during the first year and annually thereafter for moderate- and high-complexity testing). These records must be retained and made available for inspection. CLSI standards further reinforce these requirements by outlining structured training programs that define required qualifications, learning objectives, and evaluation methods. CLSI recommends documented evidence of training completion, competency evaluations, corrective retraining when needed, and maintenance of up-to-date training files for each employee as part of the laboratory’s quality management system. Together, CLIA and CLSI require comprehensive, documented training systems to ensure personnel are qualified, competent, and capable of producing accurate and reliable laboratory results.
CLIA regulations (42 CFR §493) require that laboratories properly select, validate, and maintain equipment and instruments used in testing to ensure accurate and reliable patient results. Before an instrument is placed into service, the laboratory must verify or establish performance specifications appropriate to the complexity of testing (e.g., accuracy, precision, reportable range, reference intervals), and document this verification. CLIA also requires written procedures for calibration, calibration verification, maintenance, function checks, and corrective actions when performance specifications are not met, with all activities documented and retained for inspection. CLSI standards further expand on these requirements by outlining best practices for method verification/validation, installation qualification, operational qualification, performance qualification, risk assessment, and ongoing performance monitoring within a quality management system framework. Together, CLIA and CLSI require documented implementation, validation, and lifecycle management of laboratory equipment and instruments to ensure consistent performance, traceability, and compliance with regulatory and quality standards.
CLIA regulations (42 CFR §493) require that personnel performing patient testing meet defined qualification standards based on the complexity of the testing performed (waived, moderate, or high complexity). For moderate- and high-complexity testing, individuals must meet minimum education and training requirements specified in the regulations and must receive documented training on the specific test systems they use before reporting patient results. CLIA also requires that testing personnel demonstrate competency through structured assessments, including direct observation of routine work, monitoring of result reporting, review of quality control performance, and evaluation of problem-solving skills. Competency must be assessed at least semiannually during the first year of testing and annually thereafter. In addition, testing personnel must follow the laboratory’s written procedures and may only perform testing authorized under the laboratory’s CLIA certificate and within the scope of their qualifications, ensuring that patient results are accurate, reliable, and compliant with regulatory standards.
Under the Clinical Laboratory Improvement Amendments (CLIA), laboratory testing is categorized based on the complexity of the test methodology and the level of risk to patient safety if performed incorrectly. The three primary complexity categories are waived, moderate complexity, and high complexity testing. Waived tests are simple procedures with a low risk of error and minimal potential for harm, and they must be performed strictly according to manufacturer instructions. Moderate complexity tests require more technical knowledge and oversight, including defined personnel qualifications, training, competency assessments, and quality control procedures. High complexity tests involve more sophisticated methodologies, manual interpretation, or multiple analytical steps, and are subject to the most stringent personnel requirements, validation standards, and quality system oversight. These categories determine the regulatory obligations of the laboratory, including certification type, inspection frequency, and personnel qualifications.
CLIA regulations (42 CFR §493 Subpart H) require laboratories performing moderate- and high-complexity testing to enroll in CMS-approved proficiency testing (PT) programs for each regulated analyte or specialty they report for patient testing. Laboratories must test PT samples in the same manner as patient specimens, using the same personnel, procedures, equipment, and workload conditions, and must not refer PT samples to another laboratory for analysis. PT must be performed at the required frequency—typically three testing events per year with multiple samples per event—and results must be submitted within the specified timeframe. Laboratories are required to review PT performance, document corrective actions for any unsuccessful results, and maintain PT records for inspection. Repeated unsuccessful PT performance can result in sanctions, including required retraining, limitation of testing scope, or revocation of the laboratory’s CLIA certificate. These requirements ensure ongoing external verification of analytical accuracy and reliability in patient testing.
According to CLIA regulations and CLSI quality management system standards (such as CLSI QMS01), a Quality Manual should be a controlled, high-level document that defines the laboratory’s quality policy, organizational structure, scope of services, and overall framework for meeting regulatory and accreditation requirements. CLIA requires laboratories to maintain documented policies and procedures that ensure the accuracy, reliability, and timeliness of patient test results, and the Quality Manual serves as the overarching document that describes how these requirements are implemented. CLSI further outlines that the Quality Manual should describe the laboratory’s quality management system elements, including document control, personnel qualifications and competency, equipment management, process control, occurrence management, assessment, process improvement, customer service, and facilities and safety. It should clearly define roles, responsibilities, and authority, reference supporting SOPs and records, and be reviewed and approved by laboratory leadership. Together, CLIA and CLSI position the Quality Manual as the central document that communicates the laboratory’s commitment to quality and regulatory compliance and provides a structured roadmap for maintaining an effective quality management system.
A Document Control system is a structured process for creating, reviewing, approving, distributing, revising, and archiving laboratory documents to ensure that only current, authorized versions are in use. Under CLIA regulations and CLSI quality management system standards, laboratories are required to maintain written policies and procedures that are accurate, up to date, and readily accessible to personnel. A document control system ensures that standard operating procedures (SOPs), forms, manuals, and records are properly version-controlled, reviewed at defined intervals, and protected from unauthorized changes or unintended use of obsolete documents. It also provides traceability of revisions, documented approvals, and retention of historical versions when required. Laboratories need a document control system to maintain regulatory compliance, ensure consistent performance of testing processes, reduce errors caused by outdated instructions, and demonstrate effective quality system oversight during inspections and audits.dd an answer to this item.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.